Literature DB >> 6368183

GnRH and its analogues. Current therapeutic applications and new prospects.

H M Fraser.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6368183     DOI： 10.2165/00003495-198427030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  42 in total

1.  Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.

Authors:  G Skarin; S J Nillius; L Wide
Journal:  Contraception       Date:  1982-01       Impact factor: 3.375

2.  [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].

Authors:  W Hardt; K Schmidt-Gollwitzer; J Nevinny-Stickel; M Schmidt-Gollwitzer
Journal:  Geburtshilfe Frauenheilkd       Date:  1982-12       Impact factor: 2.915

3.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.

Authors:  H M Fraser
Journal:  J Endocrinol       Date:  1981-12       Impact factor: 4.286

5.  Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH).

Authors:  W F Crowley; J W McArthur
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

6.  Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.

Authors:  C Bergquist; S J Nillius; L Wide
Journal:  Contraception       Date:  1980-10       Impact factor: 3.375

7.  Failure to induce early abortion by huge doses of a superactive LRH agonist in women.

Authors:  G Skarin; S J Nillius; L Wide
Journal:  Contraception       Date:  1982-11       Impact factor: 3.375

8.  Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone.

Authors:  A R Hoffman; W F Crowley
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

9.  Anovulatory effect of a LHRH antagonist in women.

Authors:  A Zarate; E S Canales; I Sthory; D H Coy; A M Comaru-Schally; A V Schally
Journal:  Contraception       Date:  1981-09       Impact factor: 3.375

10.  Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.

Authors:  A Lemay; A E Metha; G Tolis; N Faure; F Labrie; A T Fazekas
Journal:  Fertil Steril       Date:  1983-05       Impact factor: 7.329
View more
  3 in total

Review 1.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

Review 2.  Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.

Authors:  M G Harris; S G Coleman; D Faulds; P Chrisp
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

3.  Effect of dextran on the release of gonadotropin-releasing hormone (GnRH) injected into rats: plasma GnRH and gonadotropin response.

Authors:  N Heinrich; D Lorenz; H Berger; K Fechner; H E Schmidt; H Schäfer; B Mehlis
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.